Filter by: Subject

Filter by: Subject

Results Per Page:

Platelets (7)
Human immunodeficiency virus (HIV) (6)
Chronic myeloid leukaemia (CML) (3)
SDG-03: Good health and well-being (3)
Adenosine 50-diphosphate (2)
Antiretroviral therapy (ART) (2)
Apoptosis (2)
Calcium fluxes (2)
CD62P (2)
Haemophilia (2)
Neutrophils (2)
Phosphatidylinositol 3-kinase (2)
Pregnancy (2)
Treatment (2)
Tuberculosis (TB) (2)
2-Methoxyestradiol (2ME2) (1)
Acute leukaemia (AL) (1)
Acute myeloid leukaemia (AML) (1)
Acute myeloid leukemia (AML) (1)
Adaptive immunity (1)
Adenosine-5′-triphosphate (1)
Adult patients (1)
African ancestry (1)
AIDS (Disease) (1)
Angiogenesis (1)
Anti-factor Xa (1)
Anticoagulation (1)
Antiretroviral treatment (ART) (1)
Anti‐phospholipid syndrome (1)
Arterial thrombosis (1)
Artificial primary miRNA (1)
Autophagy (1)
Bedaquiline (1)
Beta thalassemia (1)
Binding protein-α (C/EBPα) (1)
Blood -- Collection and preservation -- Research (1)
Bone marrow (BM) (1)
Bone marrow aspirates (BMA) (1)
Cancer cells (1)
Cancer diagnoses (1)
Cardiovascular events (1)
Care testing (1)
CD4 (1)
Children (1)
Children who are HIV-exposed-but-uninfected (CHEU) (1)
Children who are HIV-unexposed–and-uninfected (CHUU) (1)
Cholesterol-dependent cytolysins (1)
Chromogenic assays (1)
Chronic leukaemia (CL) (1)
Chronic lymphocytic leukaemia (1)
Clofazimine (1)
Clot formation (1)
Community-acquired pneumonia (CAP) (1)
Consensus (1)
Coronavirus disease 2019 (COVID-19) (1)
Covalently closed circular DNA (cccDNA) (1)
COVID-19 pandemic (1)
Cytogenetics (1)
Cytopenias (1)
Cytosolic calcium (1)
Detection (1)
Diagnose (1)
Diagnosis (1)
Diagnosis, Noninvasive (1)
Diagnostic laboratories (1)
Diagnostic profiles (1)
Disease (1)
Dolutegravir (DTG) (1)
Endocrine abnormalities (1)
Ex vivo (1)
Factor VIII (FVIII) (1)
FANCG (1)
Fanconi anemia (FA) (1)
Feasibility (1)
Febrile infant (1)
Finger-stick blood. (1)
Fingersticks (1)
Flow cytometry (1)
Founder mutation (1)
Freeze-thaw (1)